These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22712836)

  • 1. Serum miR-29a as a marker of multiple myeloma.
    Sevcikova S; Kubiczkova L; Sedlarikova L; Slaby O; Hajek R
    Leuk Lymphoma; 2013 Jan; 54(1):189-91. PubMed ID: 22712836
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
    Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
    Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
    Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
    Ren Y; Li X; Wang W; He W; Wang J; Wang Y
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):415-423. PubMed ID: 28601493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
    Shen X; Ye Y; Qi J; Shi W; Wu X; Ni H; Cong H; Ju S
    Clin Chem Lab Med; 2017 May; 55(5):748-754. PubMed ID: 27155004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
    Xu YN; Xiao CR; Huang YD; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of miR-21 in multiple myeloma patients.
    Wang JH; Zhou WW; Liu BX; Man DL; Yang ZD; Liu FR; Shang H
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
    Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
    Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
    Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
    Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.
    Navarro A; Díaz T; Tovar N; Pedrosa F; Tejero R; Cibeira MT; Magnano L; Rosiñol L; Monzó M; Bladé J; Fernández de Larrea C
    Oncotarget; 2015 Jan; 6(3):1874-83. PubMed ID: 25593199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma.
    Xiang P; Liu Y; Liu L; Lin Q; Liu X; Zhang H; Xu J; Fang B
    Acta Haematol; 2019; 142(4):208-216. PubMed ID: 31163428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating exosomal microRNA as biomarkers in mutiple myeloma].
    Manier S; Leleu X; Avet-Loiseau H
    Med Sci (Paris); 2017 Nov; 33(11):939-941. PubMed ID: 29200389
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of circulating miRNAs in multiple myeloma.
    Zhang J; Xiao X; Liu J
    Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in urine are not biomarkers of multiple myeloma.
    Sedlaříková L; Bešše L; Novosadová S; Kubaczková V; Radová L; Staník M; Krejčí M; Hájek R; Ševčíková S
    J Negat Results Biomed; 2015 Sep; 14():16. PubMed ID: 26399230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum angiogenin in multiple myeloma.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kyriakou DS; Petreli E; Roussou P
    Hematol J; 2003; 4(6):454-5. PubMed ID: 14671622
    [No Abstract]   [Full Text] [Related]  

  • 19. miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients.
    Yu J; Qiu X; Shen X; Shi W; Wu X; Gu G; Zhu B; Ju S
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):543-9. PubMed ID: 24048721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevant prognostic features of multiple myeloma and the new International Staging System.
    Gertz MA
    Leuk Lymphoma; 2007 Mar; 48(3):458-68. PubMed ID: 17454585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.